Fleury, I. and Laverdure, E. (2023) “Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-cell Therapy for Indolent Lymphoma”, Canadian Hematology Today. Toronto, Canada, 2(3), pp. 5–11. doi: 10.58931/cht.2023.2338.